TTK and cancer: Problem 1 asked participants to predict molecules that bound the RETM955T-associated cancer pro-targets RET[M918T], BRAF, SRC, S6K, and did not bind the anti-targets MKNK1, TTK, ERK8, PDK1, and PAK3.